Form 497J GOLDMAN SACHS TRUST
1900 K Street, NW Washington, DC 20006-1110 +1 202 261 3300 Main +1 202 261 3333 Fax www.dechert.com
ALEXANDER C. KARAMPATSOS
+1 202 261 3402 Direct +1 617 275 8365 Fax |
January 4, 2021
VIA EDGAR
Filing Desk
U.S. Securities and Exchange Commission
Office of Filings and Information Services
Branch of Registrations and Examinations
Mail Stop 0-25
100 F Street, NE
Washington, D.C. 20549
Re: | Goldman Sachs Trust (Registrant) |
File Nos. 33-17619 and 811-05349
Post-Effective Amendment No. 826 to the Registration Statement on Form N-1A (the Amendment)
Ladies and Gentlemen:
Pursuant to Rule 497(j) under the Securities Act of 1933, as amended, the Registrant hereby certifies that (1) the Prospectuses offering the Registrants Goldman Sachs Growth Opportunities Fund, Goldman Sachs Small Cap Growth Fund, Goldman Sachs Small/Mid Cap Growth Fund, Goldman Sachs Technology Opportunities Fund, Goldman Sachs Equity Income Fund, Goldman Sachs Focused Value Fund, Goldman Sachs Large Cap Value Fund, Goldman Sachs Mid Cap Value Fund, Goldman Sachs Small Cap Value Fund and Goldman Sachs Small/Mid Cap Value Fund that would have been filed under paragraph (c) of Rule 497 would not have differed from those contained in the Amendment, and (2) the text of the Amendment has been filed electronically via EDGAR with the U.S. Securities and Exchange Commission on December 29, 2020.
January 4, 2021 Page 2 |
No fees are required in connection with this filing. If you have any questions or comments, please contact the undersigned at 202.261.3402.
Very truly yours,
/s/ Alexander C. Karampatsos
Alexander C. Karampatsos
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Centessa Pharmaceuticals (CNTA) Announces $100 Million Proposed Public Offering of American Depositary Shares
- Centessa Pharmaceuticals (CNTA) Announces Pricing of $100 Million Public Offering of American Depositary Shares
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!